These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 2673462

  • 41. Low-dose granulocyte colony-stimulating factor enables the efficient collection of peripheral blood stem cells after disease-oriented, conventional-dose chemotherapy for breast cancer, malignant lymphoma and germ cell tumor.
    Kohno A, Takeyama K, Narabayashi M, Okamoto R, Adachi I, Tobinai K, Shimoyama M.
    Bone Marrow Transplant; 1995 Jan; 15(1):49-54. PubMed ID: 7538002
    [Abstract] [Full Text] [Related]

  • 42. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF.
    Hohaus S, Goldschmidt H, Ehrhardt R, Haas R.
    Exp Hematol; 1993 Apr; 21(4):508-14. PubMed ID: 7681782
    [Abstract] [Full Text] [Related]

  • 43. Long-term culture of autologous transplanted bone marrow for acute myeloid leukaemia: evidence for an in vitro haemopoietic defect and lack of correlation with the speed of engraftment.
    Straetmans N, Ma DD, Herman P, Zenebergh A, Chang A, Deneys V, De Bruyère M, Ferrant A.
    Bone Marrow Transplant; 1995 Mar; 15(3):421-8. PubMed ID: 7599567
    [Abstract] [Full Text] [Related]

  • 44. Comparative cost analysis of autologous peripheral blood progenitor cell and bone marrow transplantation in pediatric patients with malignancies.
    Vicent MG, Madero L, Chamorro L, Madero R, Diaz MA.
    Haematologica; 2001 Oct; 86(10):1087-94. PubMed ID: 11602415
    [Abstract] [Full Text] [Related]

  • 45. Relationship of infused CFU-GM and CFU-Mk mobilized by chemotherapy with or without G-CSF to platelet recovery after autologous blood stem cell transplantation.
    Takamatsu Y, Harada M, Teshima T, Makino S, Inaba S, Akashi K, Shibuya T, Niho Y.
    Exp Hematol; 1995 Jan; 23(1):8-13. PubMed ID: 7527786
    [Abstract] [Full Text] [Related]

  • 46. [Biological screening of immuno-mediated marrow insufficiency by means of the CFU-GM assay].
    Ghizzi A, Carlo Stella C, Bonfichi M, Gorini M, Pedrazzoli P.
    Boll Soc Ital Biol Sper; 1984 Nov 30; 60(11):2179-85. PubMed ID: 6525277
    [Abstract] [Full Text] [Related]

  • 47. Long-term cultures to evaluate engraftment potential of CD34+ cells from peripheral blood after mobilization by chemotherapy with and without GM-CSF.
    Benboubker L, Domenech J, Linassier C, Desbois I, Delain M, Lamagnere JP, Colombat P, Binet C.
    Exp Hematol; 1995 Dec 30; 23(14):1568-73. PubMed ID: 8542948
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Bone marrow cell dose and kinetics of recovery following allogeneic marrow transplantation in man.
    Niederwieser D, Gratwohl A, Oberholzer M, Osterwalder B, Nissen C, Speck B.
    Blut; 1983 Dec 30; 47(6):355-60. PubMed ID: 6360252
    [Abstract] [Full Text] [Related]

  • 54. The sensitivity to hyperthermia of human granulocyte/macrophage progenitor cells (CFU-GM) derived from blood or marrow of normal subjects and patients with chronic granulocytic leukaemia.
    Blackburn MJ, Wheldon TE, Field SB, Goldman JM.
    Br J Cancer; 1984 Dec 30; 50(6):745-51. PubMed ID: 6594154
    [Abstract] [Full Text] [Related]

  • 55. Granulocyte progenitors (CFU-D) in neutrophilic leukemoid reaction are hyporesponsive to macrophage-induced inhibition.
    Hansz J, Sawiński K.
    Res Exp Med (Berl); 1988 Dec 30; 188(3):217-25. PubMed ID: 3166525
    [Abstract] [Full Text] [Related]

  • 56. No influence of number of donor CFU-GM on granulocyte recovery in bone marrow transplantation for acute leukemia.
    Torres A, Alonso MC, Gomez-Villagran JL, Manzanares MR, Martinez F, Gomez P, Garcia JM, Andres P, Gomez C, Torre MA.
    Blut; 1985 Feb 30; 50(2):89-94. PubMed ID: 3882174
    [Abstract] [Full Text] [Related]

  • 57. Undetectable peripheral blood CFU-GM as a prognostic indicator in myelodysplastic syndrome.
    Tennant GB, Jacobs A.
    Leuk Res; 1988 Feb 30; 12(11-12):961-2. PubMed ID: 3216676
    [Abstract] [Full Text] [Related]

  • 58. Daily evaluation of circulating granulocyte-monocyte progenitors during bone marrow recovery from induction therapy in acute leukemia.
    Tilly H, Vannier JP, Jean P, Bastit D, Monconduit M, Piguet H.
    Leuk Res; 1986 Feb 30; 10(3):353-6. PubMed ID: 3951255
    [Abstract] [Full Text] [Related]

  • 59. Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage.
    Fialkow PJ, Jacobson RJ, Papayannopoulou T.
    Am J Med; 1977 Jul 30; 63(1):125-30. PubMed ID: 267431
    [Abstract] [Full Text] [Related]

  • 60. Increased ratio of granulocyte/macrophage progenitor cells (CFU-GM) to multilineage progenitor cells (CFU-mix) in the peripheral blood from patients acute non-lymphoblastic leukaemia in very early remission.
    Geissler K, Hinterberger W, Lechner K.
    Br J Haematol; 1986 Mar 30; 62(3):596-7. PubMed ID: 3954971
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.